Dr. Frederick Kweh PhD.
Key expert in personalized regenerative therapeutics at ISSCA
Dr. Frederick Kweh is a prominent figure in regenerative medicine and the Co-Founder and Chief Scientific Officer at KweHealth. With over a decade of experience in basic and translational research, he is leading the development of next-generation regenerative therapeutics based on perinatal exosomes. These therapies target neurological disorders such as Parkinson’s, Alzheimer’s, Huntington’s, and chronic pain, with an emphasis on precision and personalized care.
At KweHealth, Dr. Kweh and his team are advancing a clinical-grade exosome manufacturing platform, using sophisticated AI-driven analytics to enhance treatment protocols. His work seeks to not only revolutionize treatments for neurodegenerative diseases but also set new standards in personalized regenerative medicine.
In addition to his leadership role at KweHealth, Dr. Kweh contributes to ISSCA as an instructor, where he shares his cutting-edge knowledge with healthcare professionals, empowering them to lead in the field of regenerative medicine. His work is rooted in the core values of honesty, empowerment, adaptability, resilience, and transformation, all aimed at reshaping patient care globally.
